LPS response and endotoxin tolerance in Flt-3L-induced bone marrow-derived dendritic cells

Cellular Immunology

Volumn 271, Issue 1, 2011, Pages 184-191

  Patenaude, Julie ^a   D'Elia, Michele ^a   Côté Maurais, Guillaume ^a   Bernier, Jacques ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Bone marrow; Dendritic cells; Endotoxin; Flt 3L; IL 10; IL 12; MAP kinase; MKP 1; Tolerance

Indexed keywords

ENDOTOXIN; FLT3 LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P40; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MKP 1 PHOSPHATASE; PHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL NUCLEUS; CELL STIMULATION; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELLS, CULTURED; DENDRITIC CELLS; DUAL SPECIFICITY PHOSPHATASE 1; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TOLL-LIKE RECEPTOR 4;

EID: 80052358810     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.06.020     Document Type: Article

References (37)

1. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002, 2:151-161.
2. Beg A.A. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 2002, 23:509-512.
3. Cools N., Ponsaerts P., Van Tendeloo V.F., Berneman Z.N. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J. Leukoc. Biol. 2007, 82:1365-1374.
4. Fan H., Cook J.A. Molecular mechanisms of endotoxin tolerance. J. Endotoxin. Res. 2004, 10:71-84.
5. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., Akira S. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 2000, 164:3476-3479.
6. Medvedev A.E., Henneke P., Schromm A., Lien E., Ingalls R., Fenton M.J., Golenbock D.T., Vogel S.N. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J. Immunol. 2001, 167:2257-2267.
7. Randow F., Syrbe U., Meisel C., Krausch D., Zuckermann H., Platzer C., Volk H.D. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J. Exp. Med. 1995, 181:1887-1892.
8. Medvedev A.E., Sabroe I., Hasday J.D., Vogel S.N. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J. Endotoxin. Res. 2006, 12:133-150.
9. Patenaude J., D'Elia M., Hamelin C., Bernier J. Selective effect of burn injury osplenic CD11c(+) dendritic cells and CD8alpha (+)CD4 (-)CD11c (+) dendritic cell subsets. Cell Mol. Life Sci. 2010, 67:1315-1329.
10. Toliver-Kinsky T.E., Cui W., Murphey E.D., Lin C., Sherwood E.R. Enhancement of dendritic cell production by fms-like tyrosine kinase-3 ligand increases the resistance of mice to a burn wound infection. J. Immunol. 2005, 174:404-410.
11. Bohannon J., Fang G., Cui W., Sherwood E., Toliver-Kinsky T. Fms-like tyrosine kinase-3 ligand alters antigen-specific responses to infections after severe burn injury. Shock 2009, 32:435-441.
12. Xu Y., Zhan Y., Lew A.M., Naik S.H., Kershaw M.H. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J. Immunol. 2007, 179:7577-7584.
13. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., Shortman K. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 2006, 7:663-671.
14. Naik S.H., Proietto A.I., Wilson N.S., Dakic A., Schnorrer P., Fuchsberger M., Lahoud M.H., O'Keeffe M., Shao Q.X., Chen W.F., Villadangos J.A., Shortman K., Wu L. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 2005, 174:6592-6597.
15. Brasel K., De Smedt T., Smith J.L., Maliszewski C.R. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 2000, 96::3029-3039.
16. Nakahara T., Moroi Y., Uchi H., Furue M. Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J. Dermatol. Sci. 2006, 42:1-11.
17. Dowling D., Hamilton C.M., O'Neill S.M. A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands. Cytokine 2008, 41:254-262.
18. Medvedev A.E., Kopydlowski K.M., Vogel S.N. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine and toll-like receptor 2 and 4 gene expression. J. Immunol. 2000, 164:5564-5574.
19. Chi H., Barry S.P., Roth R.J., Wu J.J., Jones E.A., Bennett A.M., Flavell R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. U S A 2006, 103:2274-2279.
20. Franklin C.C., Kraft A.S. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 1997, 272:16917-16923.
21. Zhao Q., Wang X., Nelin L.D., Yao Y., Matta R., Manson M.E., Baliga R.S., Meng X., Smith C.V., Bauer J.A., Chang C.H., Liu Y. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 2006, 203:131-140.
22. Yanagawa Y., Onoe K. Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation. J. Immunol. 2007, 178:6173-6180.
23. Naik S., Vremec D., Wu L., O'Keeffe M., Shortman K. CD8alpha+ mouse spleen dendritic cells do not originate from the CD8alpha- dendritic cell subset. Blood 2003, 102:601-604.
24. An H., Yu Y., Zhang M., Xu H., Qi R., Yan X., Liu S., Wang W., Guo Z., Guo J., Qin Z., Cao X. Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 2002, 106:38-45.
25. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001, 13:85-94.
26. Zhang S., Mantel C., Broxmeyer H.E. Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells. J. Leukoc. Biol. 1999, 65:372-380.
27. Srinivasa S.P., Doshi P.D. Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line. Leukemia 2002, 16:244-253.
28. Wang J., Wang X., Hussain S., Zheng Y., Sanjabi S., Ouaaz F., Beg A.A. Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells. J. Immunol. 2007, 178:6777-6788.
29. De Creus A., Abe M., Lau A.H., Hackstein H., Raimondi G., Thomson A.W. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J. Immunol. 2005, 174:2037-2045.
30. Ma W., Lim W., Gee K., Aucoin S., Nandan D., Kozlowski M., Diaz-Mitoma F., Kumar A. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 2001, 276:13664-13674.
31. Guo X., Gerl R.E., Schrader J.W. Defining the involvement of p38alpha MAPK in the production of anti- and proinflammatory cytokines using an SB 203580-resistant form of the kinase. J. Biol. Chem. 2003, 278:22237-22242.
32. Yao Y., Li W., Kaplan M.H., Chang C.H. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J. Exp. Med. 2005, 201:1899-1903.
33. Cao W., Bao C., Padalko E., Lowenstein C.J. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J. Exp. Med. 2008, 205:1491-1503.
34. Hammer M., Mages J., Dietrich H., Schmitz F., Striebel F., Murray P.J., Wagner H., Lang R. Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur. J. Immunol. 2005, 35:2991-3001.
35. Maldonado-opez R., Moser M. Dendritic cell subsets and the regulation of Th1/Th2 responses. Seminars Immunol. 2001, 13:275-282.
36. Efron P., Moldawer L.L. Sepsis and the dendritic cell. Shock 2003, 20:386-401.
37. Coquerelle C., Moser M. DC subsets in the positive and negative regulation of immunity. Immunol. Rev. 2010, 234:317-334.